Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor ImmunityMarit Rasmussen(University of Oslo), Jason Matthews(University of Oslo)CancersJuly 20, 202310.3390/cancers15143689Cited by 28SaveCiteExport RISWatch citationsRelated PapersPARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells|Cells|2021|74